AEterna Zentaris Inc. (AEZS)

[Waxman]

I agree it was good news. It means they are now exploring using Macrilen for pediatric applications which could double or triple the potential.

But its all window dressing IMO until the company gets FDA approval. Which they now say the type A meeting with the FDA is scheduled for later this month. If they get the go ahead then I believe you will see more than a blip of activity. But it seems share holders here are a very wary bunch, who are used to disappointment so they need to be smacked in the face with some success.

We will know a lot more in a short time, good luck all